4
Changes in Ownership
PharmaCyte Biotech, Inc. Filed Acc 0001683168-23-008431
Options or other derivatives
- Interim CEO, Interim President acquired 170,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Silverman Joshua · Interim CEO, Interim President
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-20 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +170,000 | 170,000 | D |
Loading xslF345X05/ownership.xml…